| Dr Julie M Crist, DC | |
|
12100 W Roca Rd, Crete, NE 68333-5027 | |
| (402) 826-5097 | |
| (402) 826-2892 |
| Full Name | Dr Julie M Crist |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 36 Years |
| Location | 12100 W Roca Rd, Crete, Nebraska |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699854174 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 970 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Countryside Chiropractic Pc | 1951336536 | 2 |
News Archive
The benefits of breastfeeding for both mother and child are well-recognized, including for late preterm infants. But because LPI do not have fully developed brains, they may experience difficulties latching and/or sustaining a latch on the breast to have milk transfer occur.
Americana Corporation is pleased to announce a strategic partnership with COMS Interactive, LLC (Clinical Outcomes Management Systems or COMS). The partnership supports an interface between Americana Corporation's AmeraCare products/services and the COMS Daylight IQ™ disease management software.
The study began by taking the medical history of 11 children, all of whom had a disorder due to mycobacteria infections, as the basis. All were discovered to have the same phenotype with the same mutation, which was located in the interferon-gamma (IFNGR) receptor, so the group began to explore what was causing this dysfunction.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Radboud University Nijmegen Medical Centre in the Netherlands announced today that they have published new pre-clinical results in the journal Cancer Immunology Immunotherapy describing the development of a dendritic cell (DC) cancer vaccine with enhanced immunogenic potential.
Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 5 days ago
| Provider Name | Countryside Chiropractic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497949523 PECOS PAC ID: 1951336536 Enrollment ID: O20051003000440 |
News Archive
The benefits of breastfeeding for both mother and child are well-recognized, including for late preterm infants. But because LPI do not have fully developed brains, they may experience difficulties latching and/or sustaining a latch on the breast to have milk transfer occur.
Americana Corporation is pleased to announce a strategic partnership with COMS Interactive, LLC (Clinical Outcomes Management Systems or COMS). The partnership supports an interface between Americana Corporation's AmeraCare products/services and the COMS Daylight IQ™ disease management software.
The study began by taking the medical history of 11 children, all of whom had a disorder due to mycobacteria infections, as the basis. All were discovered to have the same phenotype with the same mutation, which was located in the interferon-gamma (IFNGR) receptor, so the group began to explore what was causing this dysfunction.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Radboud University Nijmegen Medical Centre in the Netherlands announced today that they have published new pre-clinical results in the journal Cancer Immunology Immunotherapy describing the development of a dendritic cell (DC) cancer vaccine with enhanced immunogenic potential.
Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julie M Crist, DC 12100 W Roca Rd, Crete, NE 68333-5027 Ph: (402) 826-5097 | Dr Julie M Crist, DC 12100 W Roca Rd, Crete, NE 68333-5027 Ph: (402) 826-5097 |
News Archive
The benefits of breastfeeding for both mother and child are well-recognized, including for late preterm infants. But because LPI do not have fully developed brains, they may experience difficulties latching and/or sustaining a latch on the breast to have milk transfer occur.
Americana Corporation is pleased to announce a strategic partnership with COMS Interactive, LLC (Clinical Outcomes Management Systems or COMS). The partnership supports an interface between Americana Corporation's AmeraCare products/services and the COMS Daylight IQ™ disease management software.
The study began by taking the medical history of 11 children, all of whom had a disorder due to mycobacteria infections, as the basis. All were discovered to have the same phenotype with the same mutation, which was located in the interferon-gamma (IFNGR) receptor, so the group began to explore what was causing this dysfunction.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Radboud University Nijmegen Medical Centre in the Netherlands announced today that they have published new pre-clinical results in the journal Cancer Immunology Immunotherapy describing the development of a dendritic cell (DC) cancer vaccine with enhanced immunogenic potential.
Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 5 days ago
Dr. Carry R Crist, D.C, Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 12100 W Roca Rd, Crete, NE 68333 Phone: 402-826-5097 Fax: 402-826-2892 | |
Dr. Troy Allen Reistroffer, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 307 E 12th St, Crete, NE 68333 Phone: 402-826-2191 Fax: 402-826-4855 | |
Taylor Phipps, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1212 Ivy Ave, Crete, NE 68333 Phone: 402-381-3033 | |
Grant Vlasin, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 220 E 13th St, Crete, NE 68333 Phone: 402-826-5151 Fax: 402-803-1052 | |
Reistroffer Family Chiropractic, P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 307 E 12th St, Crete, NE 68333 Phone: 402-826-2191 Fax: 402-826-5844 | |
Crist Family Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 1106 Main Ave, Crete, NE 68333 Phone: 402-826-5097 Fax: 402-826-5200 | |
Dr. Bruce E Wahl, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 220 E 13th St, Crete, NE 68333 Phone: 402-826-5151 Fax: 402-826-5152 |